Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus J Couch

Showing results (111-120 of 563) with videos related to

Pageof 57
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex TestingJudith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
Cancer Research|May 3, 2008
Functional assays for classification of BRCA2 variants of uncertain significanceDaniel J Farrugia, Mukesh K Agarwal, Vernon S Pankratz, et al.
Journal of the National Cancer Institute|September 2, 2016
ResponseAmanda B Spurdle, Susan Domchek, Mark Robson, et al.
Journal of the National Cancer Institute|February 25, 2020
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing CohortChunling Hu, Eric C Polley, Siddhartha Yadav, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 10, 2004
Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomasDylan V Miller, Alexey A Leontovich, Wilma L Lingle, et al.
American Journal of Human Genetics|October 10, 2007
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genesDouglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, et al.
Research Square|February 6, 2026
Factors associated with and patterns of alcohol intake in late survivorship for breast cancer survivorsSanjna Rajput, Robert A Vierkant, Kayleigh N Olson, et al.
JCO Clinical Cancer Informatics|May 6, 2024
Assessment of <i>BRCA1</i> and <i>BRCA2</i> Germline Variant Data From Patients With Breast Cancer in a Real-World Data RegistryThales C Nepomuceno, Paulo Lyra, Jianbin Zhu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2008
Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancerXianshu Wang, Ellen L Goode, Zachary S Fredericksen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 28, 2023
Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-UpDaniela L Stan, Julian O Kim, Daniel J Schaid, et al.
Pageof 57

Showing results (111-120 of 563) with videos related to

Sort By:
Pageof 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex TestingJudith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
Cancer Research|May 3, 2008
Functional assays for classification of BRCA2 variants of uncertain significanceDaniel J Farrugia, Mukesh K Agarwal, Vernon S Pankratz, et al.
Journal of the National Cancer Institute|September 2, 2016
ResponseAmanda B Spurdle, Susan Domchek, Mark Robson, et al.
Journal of the National Cancer Institute|February 25, 2020
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing CohortChunling Hu, Eric C Polley, Siddhartha Yadav, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 10, 2004
Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomasDylan V Miller, Alexey A Leontovich, Wilma L Lingle, et al.
American Journal of Human Genetics|October 10, 2007
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genesDouglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, et al.
Research Square|February 6, 2026
Factors associated with and patterns of alcohol intake in late survivorship for breast cancer survivorsSanjna Rajput, Robert A Vierkant, Kayleigh N Olson, et al.
JCO Clinical Cancer Informatics|May 6, 2024
Assessment of <i>BRCA1</i> and <i>BRCA2</i> Germline Variant Data From Patients With Breast Cancer in a Real-World Data RegistryThales C Nepomuceno, Paulo Lyra, Jianbin Zhu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2008
Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancerXianshu Wang, Ellen L Goode, Zachary S Fredericksen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 28, 2023
Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-UpDaniela L Stan, Julian O Kim, Daniel J Schaid, et al.
Pageof 57